Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Total Current Liabilities (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Total Current Liabilities data on record, last reported at $3.0 million in Q3 2025.

  • For Q3 2025, Total Current Liabilities fell 12.34% year-over-year to $3.0 million; the TTM value through Sep 2025 reached $3.0 million, down 12.34%, while the annual FY2024 figure was $3.8 million, 20.23% down from the prior year.
  • Total Current Liabilities reached $3.0 million in Q3 2025 per UTMD's latest filing, up from $2.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $6.3 million in Q3 2022 and bottomed at $2.3 million in Q2 2025.
  • Average Total Current Liabilities over 5 years is $4.6 million, with a median of $4.4 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 59.15% in 2022, then crashed 42.78% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $3.7 million in 2021, then surged by 59.15% to $6.0 million in 2022, then decreased by 20.97% to $4.7 million in 2023, then dropped by 20.23% to $3.8 million in 2024, then fell by 19.86% to $3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $3.0 million in Q3 2025, $2.3 million in Q2 2025, and $4.3 million in Q1 2025.